Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 25 results for "Emixustat Hydrochloride"

ACUCELA : Completes Enrollment in the Emixustat Hydrochloride ...

By a News Reporter-Staff News Editor at Clinical Trials Week -- Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of ... 4 Traders, 1 month ago
[x]  

1 images for "Emixustat Hydrochloride"

Pharmaceutical Business Review, 1 month ago
Pharmaceutical Business Review

Acucela closes patient enrollment in Phase IIb/III trial of emixustat hydrochloride

Acucela, a US-based clinical-stage biotechnology firm, has completed the patient enrollment in its ongoing Phase IIb/III clinical trial evaluating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular ...
 Pharmaceutical Business Review1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less